Navigation Links
The genes involved in rheumatoid arthritis identified
Date:9/6/2007

The human genome has now been thoroughly screened in the hunt for the genetic causes of rheumatoid arthritis. The results, which both confirms previous hypotheses and turn the spotlight on entirely new genes, are presented in two articles in the prestigious New England Journal of Medicine.

Rheumatoid arthritis is the most common rheumatic disease, and affects approximately one per cent of the population. Its causes are unknown, but scientists believe that the chances of developing the disease are determined as much by genetic factors as they are by environment and lifestyle.

An international team of researchers from Sweden, the USA and Singapore, led by professors Lars Klareskog and Lars Alfredsson at the Swedish medical university Karolinska Institutet together with PhD group leader Mark Seielstad at the A*STAR funded national Genome Institute of Singapore, has compared the genomes of over 1,5000 rheumatics with those of 1,850 controls. Their analysis shows that the DNA of these two groups are at a variance at three sites, two genes previously linked to the disease and a previously unresearched gene complex known as TRAF-C5.

The Swedish and American researchers have also used the same material to examine the significance of a specific area of the genome. They found that yet another gene, STAT 4, could be linked to the disease.

The previously studied genes and the newly discovered TRAF-C5 and STAT4 genes are each important in its own way for the function of the bodys immune cells.

Its exciting that weve found new, single genes that impact on the risk of disease, but whats most important is that weve now got a broader base for understanding the mechanisms behind the development and course of the disease, says Professor Klareskog. Since the two most crucial genes are already known, this shows that were on the right track.

The studies illustrate the apparent need and growing trend towards conducting genetic r
'/>"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Genes for lung disease
3. Genesis of SUPAC
4. Cirrhosis linked to genes
5. Altering genes through calories
6. Predictable genes
7. Birth weight may be influenced by genes
8. Cardiac Valve Disease Linked To Genes
9. Genes for Vision discovered
10. Endometriosis coalesced with genes
11. New breast cancer genes discovered

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...Ennis, P.A. is offering free nationwide confidenti... control pills who have suffered a Deep Vein Throm...ack or other related cardiac issues or had their G...800-856-6405 or go to the firm’s website at ...ase evaluation form. , (P...
(Date:11/25/2009)...tinelleMedicalInc.,aleadingmanufacturerofbreastMRI...eofnewleadingedgeclinicalapplicationsonitsAegis(TM...gicalSocietyofNorthAmerica(RSNA)annualmeetinginChi...tionsleveragetheuniquehighqualityimagesgeneratedby...ltipleimagingmodalitiesformulti-parametricassessme...
(Date:11/25/2009)...siness,andPressJoinEfforttoEducate ,, MEMPHIS,...NationalBipolarFoundationandtheMedicAlertFoundatio..."program,whichisnowbeingwidelyacceptedasapreventiv...onalBipolarFoundationreceivedaproclamationofendors...orofLouisianaMitchLandrieu.TheNationalBipolarFound...
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
(Date:11/25/2009)...gns of trouble with the H1N1 vaccine, , ...ing H1N1 swine flu pandemic may be driving a recen...ents, a U.S. health official said Wednesday. , ... infections around the country," Dr. Anne Schuchat... and Respiratory Diseases at the U.S. Centers for ...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...ovider of supplemental insurance helps single wome...ection , Chicago (PRWEB) .../ [Combined Insurance], a leading provider of sup...iliate Network), marks an opportune time each year...
...reported a breakthrough test on its mesothelioma b...oma cancer. Up to this point, the number one reaso...s due to the fact that it is often misdiagnosed. ...ioma blog readers of a new scientific test that ma...
... Medical,Center received the President,s Award fro... Health Systems (NAPH) for its response in providi...st year. This award has not,been given since 2002,...Center., Twin Cities area hospitals treated 126 v...
...ceuticals,Inc. (Nasdaq: VNDA ) announced today th... Food and Drug Administration (FDA) in response to...stigational atypical antipsychotic,that was review...r which the company reported,results in December, ...
...are expressed in millions of Mexican pesos as of D...me period of 2007, unless,otherwise stated. Figure...for basis points), - Sales for the quarter total... sales were 7.19%, - The operating margin for the...
...e CHA Women,s and,Children,s Hospital in Seoul, Ko...s worldwide to win the 2008, prestigious American ...Design Award. It is one of the more,than 15 projec...oupled with this esteemed award furthers KMD,s pos...
Other Medicine News:Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 2Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 3Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 4Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 5Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 2Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 4Health News:President's Award Recognizes Hospital's Response to Bridge Collapse 2Health News:Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone 2Health News:Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone 3Health News:Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone 4Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 2Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 3Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 4Health News:KMD's CHA Hospital, Korea Wins 2008 AIA National Healthcare Award 2
(Date:11/25/2009)... FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-First...SX:HIN),aleadinginnovatorandprovideroflessinvasive...ionizingthetreatmentofadvancedheartfailure,todayan...onatthe21stAnnualPiperJaffrayHealthCareConferencea...isbeingheldattheNewYorkPalaceHotel,December1-2. ,...
(Date:11/24/2009)... PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHou...ollowinganautoaccident,wasactuallyfullyconsciousan...Americasegment.TheDynaVoxEyeMaxwasfeaturedintheseg...therconditionscanunlockcommunication. ,, WHEN:G...lineat www.dynavoxtech.com ,, WHO:RomHou...
(Date:11/24/2009)... FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Verm...panyfileditsPlanofReorganizationandDisclosureState...uptcyCourtfortheDistrictofDelaware.Ahearingtoconsi...duledforDecember8,2009,withthehearingontheconfirma...lancallsfortheCompanytopayallclaimsinfull.ThePlani...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3MedAssets Awards MEDmarketplace com Contract for Idle Capital Equipment Hospital Equipment and Supplies 49788 1MedAssets Awards MEDmarketplace com Contract for Idle Capital Equipment Hospital Equipment and Supplies 49788 2Experimental Urine Test Spots Appendicitis 49786 1Experimental Urine Test Spots Appendicitis 49786 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 1YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 3YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 4YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 5
...)--Jun 27, 2007 - Opexa,Therapeutics, Inc. (NASDAQ...commercialization of cell therapies, presented,pos... for Stem Cell,Research Annual Meeting (ISSCR) in ...at the 13th Annual Meeting of the International,So...alia from June,24-27. The two presentations covere...
...007 - Gentium S.p.A. (Nasdaq:,GENT) announced the ... that support the safety, activity, synergy and po...ination with anticancer,therapy in multiple myelom... Company,s ongoing Phase I/II clinical trial for p...ma with Defibrotide in,combination with chemothera...
Other Medicine Technology:Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 2Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 3Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
Sota Omoigui's Anesthesia Drugs Handbook
A to Z Drug Facts, 6th Edition
...f new measuring principle - Pupil Zone Imaging Met...curacy and reliability in refraction measurement.,...ovides ordinary measurement (3.3 mm) using a mire ... 4 points, both of which offer reliable and accura...
ISI Free-Standing Arm Table
Medicine Products: